(NYSE: IQV) Iqvia Holdings's forecast annual revenue growth rate of 6.17% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Iqvia Holdings's revenue in 2024 is $14,984,000,000.On average, 9 Wall Street analysts forecast IQV's revenue for 2024 to be $2,815,595,706,000, with the lowest IQV revenue forecast at $2,802,009,705,000, and the highest IQV revenue forecast at $2,829,606,780,000. On average, 9 Wall Street analysts forecast IQV's revenue for 2025 to be $3,036,804,094,500, with the lowest IQV revenue forecast at $3,002,100,750,000, and the highest IQV revenue forecast at $3,072,250,500,000.
In 2026, IQV is forecast to generate $3,253,419,625,500 in revenue, with the lowest revenue forecast at $3,167,715,870,000 and the highest revenue forecast at $3,319,999,633,500.